Serum transthyretin has several isoforms, most of which are caused by disulfide linkage with cysteine residue at position 10. We found an ion peak 80 D larger than unmodified transthyretin by electrospray ionization mass spectrometry and assigned it toS-sulfonated transthyretin. The peak height was “2% of total transthyretin in control sera from more than 200 individuals including infants. Transthyretin from a patient with molybdenum cofactor deficiency was analyzed, and the peak was prominent, higher than 85% of total transthyretin. In patients with this disease, the presence of elevated levels of sulfite leads to the formation ofS-sulfonated cysteine. The peak can be used as a diagnostic marker for molybdenum cofactor deficiency, although more sera from patients with this disease should be tested.© International Pediatrics Research Foundation, Inc. 2000. All Rights Reserved.
CITATION STYLE
Kishikawa, M., Nakanishi, T., Shimizu, A., & Yoshino, M. (2000). detection by mass spectrometry of highly increased amount of S- sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency. Pediatric Research, 47(4), 492–494. https://doi.org/10.1203/00006450-200004000-00013
Mendeley helps you to discover research relevant for your work.